Perkins Capital Management’s Biocept, Inc. BIOC Stock Holding History

Perkins Capital Management’s Portfolio BIOC Stock Details BIOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-107	Closed	-$193K	–	139
2018 Q2	$193K	Sell	107 -4	-4%	-$8.1K	0.14%	114
2018 Q1	$294K	Buy	+111	New	+$417K	0.26%	87
2015 Q2	–	Sell	-1	Closed	-$69K	–	140
2015 Q1	$69K	Sell	1 -2	-67%	-$134K	0.06%	129
2014 Q4	$178K	Hold	3	–	–	0.15%	110
2014 Q3	$205K	Sell	3 -1	-25%	-$124K	0.17%	113
2014 Q2	$698K	Buy	4 +1	+33%	+$147K	0.49%	69
2014 Q1	$657K	Buy	+3	New	+$678K	0.46%	75

Other funds holding BIOC

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Perkins Capital Management's BIOC Position: Q3 2018 in Review

Perkins Capital Management sold out of Biocept, Inc. (BIOC) in Q3 2018, closing a stake of 107 shares — an estimated $193K sold.

Perkins Capital Management first reported a position in BIOC in Q1 2014 and held it in 7 quarters. The position peaked at $698K in Q2 2014. 8 funds tracked by Wall St. Rank hold BIOC as of Q3 2018.

Perkins Capital Management reported no remaining Biocept, Inc. position as of Q3 2018 after selling out during the quarter.
Perkins Capital Management sold 107 Biocept, Inc. shares in Q3 2018, an estimated $193K.
Perkins Capital Management first reported a position in Biocept, Inc. in Q1 2014 and held it in 7 quarters.
Perkins Capital Management's Biocept, Inc. position peaked at $698K in Q2 2014.
8 funds tracked by Wall St. Rank held Biocept, Inc. as of Q3 2018.

Based on Perkins Capital Management's 13F filing for Q3 2018, filed 22 Oct 2018.